Back
ZyVersa Therapeutics Stock Price Chart
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
9
ZVSA
ZyVersa Therapeutics
Last Price:
$0.52
Seasonality Move:
-33.67%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZVSA is experiencing slight buying pressure.
ZyVersa Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.56 | Sell |
| 20-day SMA: | 0.63 | Sell |
| 50-day SMA: | 0.72 | Sell |
| 200-day SMA: | 1.58 | Sell |
| 8-day EMA: | 0.56 | Sell |
| 20-day EMA: | 0.62 | Sell |
| 50-day EMA: | 0.75 | Sell |
| 200-day EMA: | 13.73 | Sell |
ZyVersa Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 38.62 | Sell |
| Chaikin Money Flow: | 122552 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.56 - 0.78) | Sell |
| Bollinger Bands (100): | (0.69 - 1.29) | Sell |
ZyVersa Therapeutics Technical Analysis
| May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ZyVersa Therapeutics Stock
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.50 while ZVSA 8-day simple moving average is 0.56, which is a Sell signal.
-
The stock price of ZVSA is 0.50 while ZyVersa Therapeutics 20-day SMA is 0.63, which makes it a Sell.
-
ZyVersa Therapeutics 50-day simple moving average is 0.72 while ZVSA share price is 0.50, making it a Sell technically.
-
ZVSA stock price is 0.50 and ZyVersa Therapeutics 200-day simple moving average is 1.58, creating a Sell signal.
ZVSA Technical Analysis vs Fundamental Analysis
Sell
9
ZyVersa Therapeutics (ZVSA)
is a Sell
Is ZyVersa Therapeutics a Buy or a Sell?
-
ZyVersa Therapeutics stock is rated a SellThe current ZyVersa Therapeutics [ZVSA] share price is $0.50. The Score for ZVSA is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
ZyVersa Therapeutics Stock Info
Market Cap:
1.8M
Price in USD:
0.50
Share Volume:
168.5K
ZyVersa Therapeutics 52-Week Range
52-Week High:
6.30
52-Week Low:
0.47
Sell
9
ZyVersa Therapeutics (ZVSA)
is a Sell
ZyVersa Therapeutics Share Price Forecast
-
What is the ZyVersa Therapeutics stock price today?The ZyVersa Therapeutics stock price is 0.50 USD today.
-
Will ZVSA stock go up or go down?ZyVersa Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is ZyVersa Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ZyVersa Therapeutics is overvalued.
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.50 while ZVSA 8-day exponential moving average is 0.56, which is a Sell signal.
-
The stock price of ZVSA is 0.50 while ZyVersa Therapeutics 20-day EMA is 0.62, which makes it a Sell.
-
ZyVersa Therapeutics 50-day exponential moving average is 0.75 while ZVSA share price is 0.50, making it a Sell technically.
-
ZVSA stock price is 0.50 and ZyVersa Therapeutics 200-day simple moving average is 13.73, creating a Sell signal.
Fundamental Analysis of ZyVersa Therapeutics
Is ZyVersa Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.20 per share, and a decrease next year of $0.00 per share.
Technical Analysis of ZyVersa Therapeutics
Should I short ZyVersa Therapeutics stock?
-
ZVSA Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting ZyVersa Therapeutics is a Sell
-
ZyVersa Therapeutics Relative Strength Index (RSI) is 38.62, which suggest ZyVersa Therapeutics is oversold
-
The Bollinger Bands (25) for ZyVersa Therapeutics is (0.56 - 0.78), which suggest ZyVersa Therapeutics is a Sell
-
The Bollinger Bands (100) for ZyVersa Therapeutics is (0.69 - 1.29), which suggest ZyVersa Therapeutics is a Sell
* ZyVersa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.